Ortiz Á Mirko, Santander P Edgardo, Lugo P Judith
Universidad Arturo Prat, Chile.
Universidad de Zulia, República Bolivariana de Venezuela.
Rev Chilena Infectol. 2021 Aug;38(4):512-522. doi: 10.4067/S0716-10182021000400512.
Neisseria gonorrhoeae is a nonmotile, sporulated, aerobic or facultative anaerobic gram-negative diplococcus, catalase and oxidase positive. Sexually transmitted infections caused by this microorganism were established as public health problem since the 19th century, representing a great threat to human health due to its high prevalence and multi-resistance to antimicrobials. In recent decades, reports of strains resistant to penicillin, fluoroquinolones, sulfonamides, tetracycline, macrolides, and more recently to cephalosporins and azithromycin have increased. Such a panorama has generated concern worldwide, due to the increase in cases of gonorrhea associated with multi-resistant strains. In Chile, from 2010 to 2018, the National Surveillance Program for N. gonorrhoeae was developed in order to characterize this infection in the regions and record antimicrobial resistance. This review presents an updated, systematic bibliographic analysis of the main aspects of this microorganism, its response to antimicrobials, and provides diagnostic and treatment guidelines, while waiting to advance in the understanding of the molecular mechanism and the metabolic and immunological interactions that determine infection, with a view to designing an effective vaccine.
淋病奈瑟菌是一种无动力、不形成芽孢、需氧或兼性厌氧的革兰氏阴性双球菌,过氧化氢酶和氧化酶呈阳性。自19世纪以来,由这种微生物引起的性传播感染就被确认为公共卫生问题,因其高流行率和对抗菌药物的多重耐药性,对人类健康构成了巨大威胁。近几十年来,对青霉素、氟喹诺酮类、磺胺类、四环素、大环内酯类,以及最近对头孢菌素和阿奇霉素耐药的菌株报告有所增加。由于耐多药菌株所致淋病病例增多,这种情况已引起全球关注。在智利,2010年至2018年期间开展了淋病奈瑟菌国家监测计划,以了解各地区的这种感染特征并记录抗菌药物耐药情况。本综述对该微生物的主要方面、其对抗菌药物的反应进行了最新的系统文献分析,并提供了诊断和治疗指南,同时期待在了解决定感染的分子机制以及代谢和免疫相互作用方面取得进展,以期设计出一种有效的疫苗。